Covenant Partners’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $361K | Hold |
9,414
| – | – | 0.11% | 93 |
|
|
2025
Q1 | $365K | Hold |
9,414
| – | – | 0.12% | 90 |
|
|
2024
Q4 | $318K | Sell |
9,414
-1
| -0% | -$34 | 0.1% | 108 |
|
|
2024
Q3 | $385K | Sell |
9,415
-1,180
| -11% | -$48.2K | 0.11% | 108 |
|
|
2024
Q2 | $408K | Buy |
10,595
+1,181
| +13% | +$45.5K | 0.12% | 110 |
|
|
2024
Q1 | $404K | Hold |
9,414
| – | – | 0.12% | 116 |
|
|
2023
Q4 | $349K | Sell |
9,414
-985
| -9% | -$36.5K | 0.11% | 128 |
|
|
2023
Q3 | $377K | Buy |
+10,399
| New | +$377K | 0.14% | 118 |
|
|
2022
Q3 | – | Sell |
-8,664
| Closed | -$471K | – | 175 |
|
|
2022
Q2 | $471K | Hold |
8,664
| – | – | 0.22% | 89 |
|
|
2022
Q1 | $472K | Buy |
+8,664
| New | +$472K | 0.19% | 103 |
|